C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
12/2006
12/05/2006	US7144918 Enzyme inhibitors; anticancer agents
12/05/2006	US7144897 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
11/2006
11/30/2006	WO2006125688A1 Benzoyl-substituted serine amides
11/30/2006	WO2006125550A1 Method for producing tetrahydropyranes from tetrahydropyran-3-ones
11/30/2006	WO2006125530A1 Tetrahydropyrane derivatives comprising several rings containing oxygen and method for the production thereof
11/30/2006	WO2006125529A1 Formyltetrahydropyrans, method for the production thereof and use thereof in the production of liquid crystal compounds
11/30/2006	WO2006125527A1 Method for producing tetrahydropyran derivatives
11/30/2006	WO2006125526A1 Method for producing 2,5-substituted tetrahydropyran derivatives by reductive elimination of the corresponding 4-halogen derivative
11/30/2006	WO2006109075A3 Hydroxybenzamide derivatives and their use as inhibitors of hsp90
11/30/2006	US20060270862 Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
11/30/2006	US20060270617 HkI10311129, novel antibiotic, method for producting the same and the use thereof
11/30/2006	DE102006023335A1 Liquid crystalline medium with a nematic phase, useful in electro optical display, comprises a pyran compound
11/30/2006	DE102006020181A1 Liquid crystal medium with a nematic phase, useful in electro optical display, comprises a pyran-containing component
11/30/2006	CA2609254A1 Benzoyl-substituted serine amides
11/29/2006	CN1871227A Antitumoral agent
11/29/2006	CN1871202A Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters
11/29/2006	CN1286809C Arylphenyl-substituted cyclic ketoenols compound
11/28/2006	US7141681 Continuous process for preparing dihydropyrones
11/28/2006	US7141602 Process for obtaining HMG-CoA reductase inhibitors of high purity
11/28/2006	CA2375524C 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/23/2006	WO2006123355A2 Novel statin derivatives
11/23/2006	WO2006034004A3 Processes and intermediates for preparing cysteine protease inhibitors
11/23/2006	US20060264424 Arylsulfonamidobenzylic compounds
11/22/2006	EP1723097A1 Ester derivatives of rhein and their therapeutic use
11/22/2006	EP1722863A1 Microcapsules with uv filter activity and process for producing them
11/22/2006	EP1515931B1 3,3,4,4-tetrafluorocyclopentane compounds, used as components of liquid crystal media
11/22/2006	EP1501815B1 Substituted phenylacetamides and their use as glucokinase activators
11/22/2006	EP1454905B1 Novel substance fki-1083 and process for producing the same
11/22/2006	CN1867554A Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors
11/22/2006	CN1865219A 2- and 2,5-substituted phenylketo-enols
11/22/2006	CN1285591C Dimeric compounds and their use as anti-viral agents
11/21/2006	US7138550 Bridged carbocyclic compounds and methods of making and using same
11/21/2006	US7138531 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
11/21/2006	CA2187523C Pyranone compounds useful to treat retroviral infections
11/16/2006	WO2006121150A1 (meth)acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and method for forming pattern
11/16/2006	WO2006121095A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same
11/16/2006	US20060258733 Process for the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives
11/16/2006	US20060258559 Valerolactone compounds and perfume composition
11/16/2006	CA2835779A1 Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
11/16/2006	CA2607939A1 Process for production of 4-biphenylyazetidin-2-ones
11/15/2006	EP1721522A2 Substituted phenylketo-enoles as biocides and herbicides
11/15/2006	EP1720849A1 Pyranone derivatives useful for treating cancer
11/15/2006	CN1861589A Naphthalene alkoxy and naphthaquinone kind pyrane carbonic glucoside compound and preparation process thereof
11/15/2006	CN1284793C C-aryl glucoside sglt2 inhibitors
11/15/2006	CN1284763C Compound for preparing protease inhibitor
11/14/2006	CA2342271C Gem substituted hydroxamic acids
11/09/2006	WO2006117360A1 CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-[4-((R)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
11/09/2006	WO2006117359A1 CRYSTALLINE FORM OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
11/09/2006	WO2006042007A3 Chromenone compounds as calcilytics
11/09/2006	US20060252814 Formulation comprising a betablocker and optionally a cholestrol-lowering agent
11/09/2006	US20060251742 CO2 extraction techniques provide reduced levels of methysticin and dihydromethysticin with increased levels of kavain and dihydrokavain; paste, powder, liquid, or rapid-dissolve tablet; enhances efficacy of a botanical extract co-ingredient
11/09/2006	US20060251715 Oral delivery of a botanical
11/09/2006	CA2607556A1 C-linked glucoronide of n-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth
11/09/2006	CA2606679A1 Crystalline forms of 1-chloro-4-(.beta.-d-glucopyranos-1-yl)-2-[4-((r)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
11/09/2006	CA2606650A1 Crystalline form of 1-chloro-4-(.beta.-d-glucopyranos-1-yl)-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
11/08/2006	EP1296716B1 Use of a beta-blocker for the treatment of atherosclerosis
11/08/2006	CN1283633C Process for the preparation of simvastatin
11/08/2006	CN1283611C Novel fatty acid analogous
11/08/2006	CN1283610C Ketone compounds and compositions for cholesterol management and related uses
11/07/2006	US7132447 Substance FKI-1083 and process for producing the same
11/07/2006	US7132092 Metallized mesoporous silicate and method of oxidation with the same
11/02/2006	EP1717221A1 Processes for production of alpha-aminooxyketones and alpha-hydroxyketones
11/02/2006	EP1716100A2 Therapeutic amide derivatives
11/02/2006	EP1301458A4 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis
11/01/2006	CN1856461A Cycloalkylidene compounds as modulators of estrogen receptor
11/01/2006	CN1282645C Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
10/2006
10/31/2006	US7129238 such as (S)-N-(4-Carbamimidoyl-benzyl)-2-methoxy-2-phenyl-acetamide hydrochloride, for inhibiting formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor
10/26/2006	WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/26/2006	DE10196976B4 Durch reaktionskontrollierten Phasentransferkatalysator katalysiertes Oxidationsreaktionsverfahren By reaction controlled phase transfer catalyst catalyzed oxidation reaction process
10/25/2006	EP1714958A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide
10/25/2006	EP1669357A4 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[ 2,3-d,6,5-d'] dipyrimidine and 10-aza-analogue thereof
10/25/2006	CN1853141A Compound for resist and radiation-sensitive composition
10/25/2006	CN1852885A Method for producing nitrile compound, carboxylic acid compound or carboxylate compound
10/25/2006	CN1850815A Long-chain alkoxy alkyl substituted sialic acid derivatives and preparing method thereof
10/25/2006	CN1281596C Process for the preparation of 4-oxytetrahydropyran-2-ones
10/25/2006	CN1281130C Use of ester compound for controlling harmful arthropod
10/24/2006	CA2310398C 5h-pyrano[2,3-d:6,5-d']dipyrimidine derivatives having an antibacterial, antiviral and immuno-modulating activity
10/19/2006	WO2006108802A1 Catalytic preparation of cyclic carboxylic esters
10/19/2006	WO2006108591A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
10/19/2006	WO2005087700A3 Bisphenyl compounds useful as vitamin d3 receptor agonists
10/19/2006	US20060235240 Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters
10/19/2006	US20060235073 Diamino-functional chalcones
10/19/2006	US20060234999 Natural, synthetic or semi-synthetic crude harringtonines purified by chromatography and crystallization in which the solvent is water or lower C1-4 alkanol or an aqueous mixture of organic solvents; treatment of cancer through oral administration
10/19/2006	CA2602237A1 Catalytic preparation of cyclic carboxylic esters
10/19/2006	CA2601986A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
10/18/2006	EP1711508A1 6r-(3,6-dideoxy-l-arabino-hexopyranosyloxy)heptanoic acid, preparation process for the same and dauer effect thereof
10/18/2006	EP1265604B1 Process for recovering statin compounds from a fermentation broth
10/18/2006	CN1280271C Arylphenyl-substituted cyclic keto-enols
10/17/2006	US7122686 Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
10/12/2006	WO2005121114A3 1,5 and 1,4-anhydroketoses, methods for the preparation of 1,5-and 1,4-anhydroketoses, intermediates, and uses of 1,5-and 1,4-anhydroketoses
10/12/2006	US20060229321 Rosuvastatin in pre demented states
10/12/2006	US20060229281 Cycloalkyl-Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
10/11/2006	EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
10/11/2006	EP1469851B1 Melanocortin receptor agonists
10/11/2006	EP1430045B1 Pyrane derivatives as both ace- and nep-inhibitors
10/11/2006	EP1334960B1 Method for preparing ester condensate
10/11/2006	CN1279034C Dna－pk抑制剂 Dna-pk inhibitors
10/10/2006	US7119221 treating and preventing a variety of diseases and conditions such as aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic retinopathy, dyslipidemia, dyslipoproteinemia, hypertension, impotence, insulin resistance, peroxisome proliferator activated receptor associated disorders
10/10/2006	US7119213 Pharmacologically active isolated or purified dauer pheromone compound for controlling aging and stress and method for isolating and characterizing the same
10/10/2006	US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors

1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 129